China Universal Asset Management Co., Ltd. Allogene Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 32,348 shares of ALLO stock, worth $68,577. This represents 0.02% of its overall portfolio holdings.
Number of Shares
32,348
Previous 32,348
-0.0%
Holding current value
$68,577
Previous $145,000
0.69%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding ALLO
# of Institutions
164Shares Held
106MCall Options Held
97.5KPut Options Held
45.6K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$39.7 Million1.76% of portfolio
-
Black Rock Inc. New York, NY9.65MShares$20.5 Million0.0% of portfolio
-
State Street Corp Boston, MA9.18MShares$19.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.21MShares$17.4 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA5.45MShares$11.6 Million0.02% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $305M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...